SCHEMBL2411752

SCHEMBL2411752

CC(CCO)N1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
FDPS P14324 2/20 0.33
DPP7 Q9UHL4 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A3 Q01959 1/20 0.30
KDM4E B2RXH2 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3272375 0.98 MAPT (0.35) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL9801558 0.86 SMN1; SMN2 (0.33) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23869469 0.85 CYP3A4 (0.38) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL21540021 0.85 CYP3A4 (0.38) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL25365456 0.84 ALDH1A1 (0.33) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL27695746 0.82 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1POLBMAPTTDP1
SCHEMBL14915004 0.80 MAPT (0.36) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL14915002 0.80 MAPT (0.36) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL4121949 0.80 MAPT (0.36) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL14856128 0.80 MAPT (0.36) SMN1; SMN2CYP3A4CYP2D6CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374853-A1 Cyanate ester-based pressure sensitive adhesive CORNERSTONE RESEARCH GROUP, INC. (US) 2011-10-12 EP claimed
US-20100137554-A1 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RESEARCH GROUP, INC. 2010-06-03 US claimed
US-20110294749-A1 DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2011-12-01 US disclosed
US-20110294749-A1 DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2011-12-01 US disclosed
EP-1518855-B1 DIAMINOPYRIMIDINECARBOXA MIDE DERIVATIVE ASTELLAS PHARMA INC (JP) 2011-10-26 EP disclosed
US-8039572-B2 Shape memory cyanate ester copolymers CORNERSTONE RESEARCH GROUP, INC. (US) 2011-10-18 US disclosed
EP-2374831-A1 Cyanate ester-based elastomer CORNERSTONE RESEARCH GROUP, INC. (US) 2011-10-12 EP disclosed
EP-2374853-A1 Cyanate ester-based pressure sensitive adhesive CORNERSTONE RESEARCH GROUP, INC. (US) 2011-10-12 EP disclosed
EP-1979397-B1 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RES GROUP INC (US) 2011-09-07 EP disclosed
US-8012959-B2 Diaminopyrimidinecarboxamide derivative ASTELLAS PHARMA INC. (JP) 2011-09-06 US disclosed
US-8012959-B2 Diaminopyrimidinecarboxamide derivative ASTELLAS PHARMA INC. (JP) 2011-09-06 US disclosed
US-20100137554-A1 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RESEARCH GROUP, INC. 2010-06-03 US disclosed
US-20090281072-A1 Diaminopyrimidinecarboxamide Derivative ASTELLAS PHARM INC. (JP) 2009-11-12 US disclosed
US-20090281072-A1 Diaminopyrimidinecarboxamide Derivative ASTELLAS PHARM INC. (JP) 2009-11-12 US disclosed
US-7449456-B2 Diaminopyrimidinecarboxamide derivative ASTELLAS PHARMA, INC. (JP) 2008-11-11 US disclosed
US-7449456-B2 Diaminopyrimidinecarboxamide derivative ASTELLAS PHARMA, INC. (JP) 2008-11-11 US disclosed
US-20080021188-A1 Shape Memory Cyanate Ester Copolymers CORNERSTONE RESEARCH GROUP, INC. 2008-01-24 US disclosed
WO-2005108448-A1 SHAPE MEMORY CYANATE ESTER COPOLYMERS CORNERSTONE RESEARCH GROUP, INC. (US) 2005-11-17 WO disclosed
US-4992150-A Telomer with alpha-olefin;oil and fuel additive NIPPON OIL CO, LTD. (JP) 1991-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294749-A1 DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE STAT6, STAT4, STAT3 SMN1; SMN2 4649/4885CYP3A4 2896/4885CYP2D6 476/4885
US-20090281072-A1 Diaminopyrimidinecarboxamide Derivative STAT6, STAT4, STAT3 SMN1; SMN2 4649/4885CYP3A4 2896/4885CYP2D6 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.